Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
43
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database

Sen WangDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
,
Wei-Cheng GaoDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
,
San-San ChenDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
,
Liang BaiDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
,
Li LuoDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
,
Xiang-Guang ZhengDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
&
You LuoDepartment of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, ChinaCorrespondence[email protected]
 show all
Pages 5311-5315 | Published online: 08 Nov 2017

References

  • ElseTKimACSabolchAAdrenocortical carcinomaEndocr Rev201435228232624423978
  • KerkhofsTMVerhoevenRHVan der ZwanJMAdrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993Eur J Cancer201349112579258623561851
  • AminiNMargonisGAKimYCurative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrenceAnn Surg Oncol201623112613326282907
  • StiglianoAChiodiniIGiordanoRManagement of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE)J Endocrinol Invest201639110312126165270
  • ElseTWilliamsARSabolchAJollySMillerBSHammerGDAdjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinomaJ Clin Endocrinol Metab201499245546124302750
  • TerzoloMAngeliAFassnachtMAdjuvant mitotane treatment for adrenocortical carcinomaN Engl J Med2007356232372238017554118
  • FassnachtMTerzoloMAllolioBFIRM-ACT Study GroupCombination chemotherapy in advanced adrenocortical carcinomaN Engl J Med2012366232189219722551107
  • LughezzaniGSunMPerrottePThe European Network for the Study of adrenal tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validationEur J Cancer201046471371920044246
  • FassnachtMJohanssenSQuinklerMLimited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classificationCancer2009115224325019025987
  • GaujouxSMihaiRjoint working group of ESES and ENSATEuropean Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinomaBr J Surg2017104435837628199015
  • KerkhofsTMVerhoevenRHBonjerHJDutch Adrenal NetworkSurgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry dataEur J Endocrinol20131691838923641018
  • SimonGPattouFMirallieESurgery for recurrent adrenocortical carcinoma: a multicenter retrospective studySurgery2017161124925627855966
  • ErdoganIDeutschbeinTJurowichCGerman Adrenocortical Carcinoma Study GroupThe role of surgery in the management of recurrent adrenocortical carcinomaJ Clin Endocrinol Metab201398118119123150691
  • LibeRBorgetIRonchiCLPrognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) studyAnn Oncol201526102119212526392430
  • KimYMargonisGAPrescottJDNomograms to predict recurrence-free and overall survival after curative resection of adreno-cortical carcinomaJAMA Surg2016151436537326676603
  • MargonisGAKimYPrescottJDAdrenocortical carcinoma: impact of surgical margin status on long-term outcomesAnn Surg Oncol201623113414126286195
  • MargonisGAKimYTranTBOutcomes after resection of cortisol-secreting adrenocortical carcinomaAm J Surg201621161106111326810939
  • ScolloCRussoMTrovatoMAPrognostic factors for adrenocortical carcinoma outcomesFront Endocrinol (Lausanne)201679927504106
  • ReibetanzJJurowichCErdoganIImpact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinomaAnn Surg2012255236336922143204
  • GerryJMTranTBPostlewaitLMLymphadenectomy for adrenocortical carcinoma: is there a therapeutic benefit?Ann Surg Oncol201623Suppl 5708713
  • NilubolNPatelDKebebewEDoes lymphadenectomy improve survival in patients with adrenocortical carcinoma? a population-based studyWorld J Surg201640369770526510563
  • TerzoloMBaudinAEArditoAMitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resectionEur J Endocrinol2013169326327023704714
  • LoncarZDjukicVZivaljevicVSurvival and prognostic factors for adrenocortical carcinoma: a single institution experienceBMC Urol2015154326013141
  • MaiterDBexMVroonenLEfficacy and safety of mitotane in the treatment of adrenocortical carcinoma: a retrospective study in 34 Belgian patientsAnn Endocrinol (Paris)201677557858527063476
  • PostlewaitLMEthunCGTranTBOutcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma GroupJ Am Coll Surg2016222448049026775162

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.